BARDA

The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has launched the Small Molecule Approaches for Rapid and Robust Treatment (SMART) Antiviral Prize. This opportunity, introduced in collaboration with BARDA Accelerator Network, VITAL,  is a $100

RPPV-26-07-ASSURE-Amendment-2 The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR), has released a new opportunity under the Rapid Response Partnership Vehicle (RRPV): the Assay Development for Superior Understanding of Response and Efficacy (ASSURE) program. Designed to strengthen national health security, ASSURE seeks to accelerate the development

BARDA RRPV-26-09-AgDx Request for Project Proposals The Biomedical Advanced Research and Development Authority (BARDA) has released a new Request for Project Proposals (RPP-26-09-AgDx) through the Rapid Response Partnership Vehicle (RRPV), seeking to revolutionize the nation’s diagnostic readiness for infectious disease threats. Managed by Advanced Technology International (ATI), the RRPV enables collaboration between industry, academia, and

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has issued a new Request for Project Proposals (RPP-26-10-VHF) under its Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium). This solicitation represents a key step in building domestic capacity for advanced vaccine manufacturing to strengthen the nation’s biosecurity infrastructure.